VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT06878547
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 20 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ultrasound — DEVICENon-invasive breast imaging using VisR ultrasound
Study Details
Purpose: This study will evaluate how measurements of tissue stiffness, viscosity, and anisotropy using non-invasive ultrasound imaging correlate with breast tumor malignancy and response to chemotherapy. Participants: Up to 200 women with benign or malignant breast tumors for arm 1 and up to 50 women undergoing neoadjuvant chemotherapy in the breast for arm 2 will be recruited. Procedures (methods): The research team will use an ultrasound scanner to acquire non-invasive elastography data from the breast of each subject, testing a range of transducer rotation angles. Transducer position will be monitored using a position sensor during imaging.
Key Dates
- Start date
- Mar 7, 2025
- Status verified
- May 2026
- Primary completion
- Aug 25, 2027
- Completion
- Feb 24, 2028
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Women with benign breast massesParticipants in this group will be imaged once prior to biopsy, as part of the first study arm
- Arm: Women with malignant breast massesParticipants in this group will be imaged once prior to biopsy, as part of the first study arm
- Arm: Women undergoing neoadjuvant systemic therapy (NAT)Participants in this group will be imaged once before starting NAT, once approximately midway through NAT, and once after completion of NAT, as part of the second study arm
Primary Outcome Measure
ARFI Peak Displacement (PD) in lesion (Study Arm 1) [ Time Frame: Baseline imaging ]
Central Contacts
- Desma Jones919-843-9463
- Caterina Gallippi, PhD9198436647
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27514 |
Find similar trials in Chapel Hill, NC
Related Studies
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama